242 related articles for article (PubMed ID: 33861538)
1. Pelvic lymph node dissection in high-risk prostate cancer.
Haiquel L; Cathelineau X; Sanchez-Salas R; Macek P; Secin F
Int Braz J Urol; 2022; 48(1):54-66. PubMed ID: 33861538
[TBL] [Abstract][Full Text] [Related]
2. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
3. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
[TBL] [Abstract][Full Text] [Related]
4. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
Heidenreich A; Ohlmann CH; Polyakov S
Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
[TBL] [Abstract][Full Text] [Related]
5. The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Narita T; Koie T; Ookubo T; Mitsuzuka K; Narita S; Yamamoto H; Inoue T; Hatakeyama S; Kawamura S; Tochigi T; Habuchi T; Arai Y; Ohyama C
Med Oncol; 2017 Jan; 34(1):1. PubMed ID: 27889880
[TBL] [Abstract][Full Text] [Related]
6. Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram.
Kazzazi A; Djavan B
Can J Urol; 2011 Apr; 18(2):5585-91. PubMed ID: 21504645
[TBL] [Abstract][Full Text] [Related]
7. Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis.
Cacciamani GE; Maas M; Nassiri N; Ortega D; Gill K; Dell'Oglio P; Thalmann GN; Heidenreich A; Eastham JA; Evans CP; Karnes RJ; De Castro Abreu AL; Briganti A; Artibani W; Gill I; Montorsi F
Eur Urol Oncol; 2021 Apr; 4(2):134-149. PubMed ID: 33745687
[TBL] [Abstract][Full Text] [Related]
8. Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial.
Touijer KA; Sjoberg DD; Benfante N; Laudone VP; Ehdaie B; Eastham JA; Scardino PT; Vickers A
Eur Urol Oncol; 2021 Aug; 4(4):532-539. PubMed ID: 33865797
[TBL] [Abstract][Full Text] [Related]
9. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
[TBL] [Abstract][Full Text] [Related]
10. The role of extended pelvic lymphadenectomy with radical prostatectomy for high-risk prostate cancer.
Harbin AC; Eun DD
Urol Oncol; 2015 May; 33(5):208-16. PubMed ID: 25547974
[TBL] [Abstract][Full Text] [Related]
11. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database.
Chen J; Wang Z; Zhao J; Zhu S; Sun G; Liu J; Zhang H; Zhang X; Shen P; Shi M; Zeng H
Sci Rep; 2019 Nov; 9(1):17985. PubMed ID: 31784574
[TBL] [Abstract][Full Text] [Related]
12. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
Gakis G; Boorjian SA; Briganti A; Joniau S; Karazanashvili G; Karnes RJ; Mattei A; Shariat SF; Stenzl A; Wirth M; Stief CG
Eur Urol; 2014 Aug; 66(2):191-9. PubMed ID: 23735200
[TBL] [Abstract][Full Text] [Related]
13. Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy.
Schiffmann J; Haese A; Leyh-Bannurah SR; Salomon G; Steuber T; Schlomm T; Boehm K; Beyer B; Larcher A; Michl U; Heinzer H; Huland H; Graefen M; Karakiewicz PI
Eur J Surg Oncol; 2015 Nov; 41(11):1547-53. PubMed ID: 26117216
[TBL] [Abstract][Full Text] [Related]
14. The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period.
Gandaglia G; Trinh QD; Hu JC; Schiffmann J; Becker A; Roghmann F; Popa I; Tian Z; Perrotte P; Montorsi F; Briganti A; Karakiewicz PI; Sun M; Abdollah F
Eur J Surg Oncol; 2014 Sep; 40(9):1080-6. PubMed ID: 24411705
[TBL] [Abstract][Full Text] [Related]
15. Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer.
Fujimoto N; Shiota M; Tomisaki I; Minato A; Yahara K
Urol Int; 2019; 103(2):125-136. PubMed ID: 31039571
[TBL] [Abstract][Full Text] [Related]
16. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
[TBL] [Abstract][Full Text] [Related]
17. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
[TBL] [Abstract][Full Text] [Related]
18. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.
Leyh-Bannurah SR; Budäus L; Zaffuto E; Pompe RS; Bandini M; Briganti A; Montorsi F; Schiffmann J; Shariat SF; Fisch M; Chun F; Huland H; Graefen M; Karakiewicz PI
Urol Oncol; 2018 Feb; 36(2):81.e17-81.e24. PubMed ID: 29248430
[TBL] [Abstract][Full Text] [Related]
19. The role of lymph node dissection in the management of prostate cancer.
Miki J; Egawa S
Int J Clin Oncol; 2011 Jun; 16(3):195-202. PubMed ID: 21556799
[TBL] [Abstract][Full Text] [Related]
20. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
